Pseudoexfoliative glaucoma
PDF (Español (España))

Keywords

pseudoexfoliative glaucoma, optical coherence tomography (OCT), Selective Laser Trabeculoplasty (SLT), clinical case.

How to Cite

quezada, paula. (2024). Pseudoexfoliative glaucoma . Revista Estudiantil CEUS (Ciencia Estudiantil Unidad De Salud), 5(2), 9-12. Retrieved from https://ceus.ucacue.edu.ec/index.php/ceus/article/view/163

ARK

http://resolve.scienceontheweb.net/ark:/89949/ceus.v5i2.163

Abstract

Pseudoexfoliative glaucoma is a chronic progressive optic neuropathy distinguished by the presence of grayish fibrillar material in the anterior segment of the eye. The clinical picture varies and may include elevated IOP due to aqueous humor blockage, cataract, visual field loss, optic nerve damage and phacodonesis resulting from the deposition of exfoliative material. SPEX can have genetic, environmental, or dietary origins. In this case, the patient has a history of hypertension and hypercholesterolemia, and has undergone cataract surgery in both eyes. The diagnosis of SPEX was made based on the patient’s clinical history and physical examination, which revealed the presence of pseudoexfoliative material in intraocular lenses and the pupillary border. The IOP in the right eye was measured at 25 mmHg and 26 mmHg in the left eye. Complementary examinations, such as visual field study, optic nerve photography, and OCT, among others, confirmed the diagnosis. Those studies were favorable in the diagnosis and determining the treatment. Finally, the treatment involved pharmacological and surgical interventions. A Selective Laser Trabeculoplasty (SLT) was performed in both eyes, using1M mJ energy, to facilitate the drainage of the aqueous humor, and, therefore, reduce the IOP. After three months of SLT and therapy with a triple hypotensive combination, the patient’s tonometry results were as follows: Right Eye: 12 mmHg, Left Eye: 11 mmHg. These results indicate a favorable therapeutic outcome in terms of controlling PIO values, suggesting less progression of glaucoma in the future. The patient is monitored every three months for PIO measurements, obtaining similar values during the two-year follow-up period. The patient has reported fewer symptoms, and shown compliance and promising therapeutic adherence. SLT should be considered as a therapeutic alternative that improves the patient's quality of life and preserves vision in the long term, as observed in this case.

PDF (Español (España))

References

1. Spinel Peñuela JE, Del Pilar M, Md A. Spinel-Sindrome PSX en guatemala Pseudoexfoliation syndrome at the clinic of glaucoma of the national unit of ophthalmology. Guatemala city. Cross-sectional study I N F O R M A C I Ó N A R T Í C U L O. Vol. 51. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-911877
2. Nobl M, Mackert M. Síndrome de pseudoexfoliación y glaucoma. Klin Monbl Augenheilkd. 2019;236(9):1139–55. Disponible en: https://epub.ub.uni-muenchen.de/79251/
3. Velázquez Pinillos NM, Pérez Marrero MJ, Rodríguez López EI, Tirado Garcés CM. Pseudoexfoliación ocular: un signo de alerta temprana de enfermedades sistémicas. Rev Cuba Oftalmol.2020. Disponible en https://orcid.org/0000-0002-4853-9107
4. Sánchez Acosta L, Rodríguez Suárez B, Méndez Duque de Estrada AM, Cárdenas Chacón D, Nafeh Mengua MI. Caracterización clínica y epidemiológica del síndrome pseudoexfoliativo. Rev Cuba Oftalmol. 2020. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762020000400005.
5. Bourouki E, Oikonomou E, Moschos M, Siasos G, Siasou G, Gouliopoulos N, et al. Pseudoexfoliative glaucoma, endothelial dysfunction, and arterial stiffness: The role of circulating apoptotic endothelial microparticles. J Glaucoma. 2019;28(8):749–55.
6. Łukasik U, Kosior-Jarecka E, Wróbel-Dudzińska D, Kustra A, Milanowski P, Żarnowski T. Clinical features of pseudoexfoliative glaucoma in treated polish patients. Clinical Ophthalmology. 2020;14:1373–81.
7. Yaz YA, Yıldırım N, Yaz Y, Tekin N, İnal M, Şahin FM. Role of oxidative stress in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Turk J Ophthalmol. 2019;49(2):61–7.
8. Tekcan H, Alpogan O, Imamoglu S. Pseudoexfoliation Glaucoma as a Predictor of Refractive Surprise After Uneventful Cataract Surgery. J Glaucoma [Internet]. 2023;32(4):272–9. Available from: https://journals.lww.com/10.1097/IJG.0000000000002187
9. Pantalon A, Feraru C, Tarcoveanu F, Chiselita D. Success of primary trabeculectomy in advanced open angle glaucoma. Clinical Ophthalmology. 2021;15:2219–29.
10. Journal O, Lopes AS, Fernando ;, Vaz T, Henriques S, Lisboa M, et al. Medical Hypothesis, Discovery &Innovation Outcomes of Trabeculectomy With and Without Mitomycin C in Pseudoexfoliative Glaucoma Compared With Mitomycin C in Primary Open Angle Glaucoma. Vol. 8, Med Hypothesis Discov Innov Ophthalmol. 2019.
11. Hutnik C, Crichton A, Ford B, Nicolela M, Shuba L, Birt C, et al. Selective Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in Glaucoma Patients Treated Previously with 360° Selective Laser Trabeculoplasty: A Randomized, Single-Blind, Equivalence Clinical Trial. Ophthalmology. 2019;126(2):223–32.
12. Chen G, Li J, Lv H, Wang S, Zuo J, Zhu L. Mesoporous coxsn(1 - x)o2 as an efficient oxygen evolution catalyst support for spe water electrolyzer. R Soc Open Sci. 2019;6(4).
13. Tran E, Sanvicente C, Hark LA, Myers JS, Zhang Q, Shiuey EJ, et al. Educational intervention to adopt selective laser trabeculoplasty as first-line glaucoma treatment: Randomized controlled trial: Educational intervention on selective laser trabeculoplasty. Eur J Ophthalmol. 2022;32(3):1538–46.
14. Ilveskoski L, Taipale C, Tuuminen R. Selective laser trabeculoplasty in exfoliative glaucoma eyes with prior argon laser trabeculoplasty. Acta Ophthalmol. 2020;98(1):58–64.
15. Tawfique K, Khademi P, Quérat L, Khadamy J, Chen E. Comparison between 90-degree and 360-degree selective laser trabeculoplasty (SLT): A 2-year follow-up. Acta Ophthalmol. 2019;97(4):427–9.

Downloads

Download data is not yet available.